AI supports drug discovery, clinical trials, quality control, and manufacturing optimization across Ireland’s global pharmaceutical and biotech operations.
AI-driven virus taxonomy offers a blueprint for stable, scalable classification in pharma—spanning drug discovery, QC, and clinical trials.
Human-to-mouse variant mapping improves GEMM accuracy. See how H2M predicts modellable variants and speeds genome editing for drug discovery.
FDA’s rare disease pathway rewards fast, coherent evidence. See where AI fits—from natural history to CMC—to help teams move individualized therapies faster.
Ireland hit €491M in lifesciences VC. Here’s what it signals for AI diagnostics, medtech, and pharma ops—and how to act on it.
Glyco-immune checkpoints like Siglecs may explain immunotherapy resistance. See how AbLecs and AI can help target tumor glycans for better response.
Glycan-targeting immunotherapy with AbLecs blocks sugar-driven immune suppression in cancer. See how AI can speed target discovery, design, and trials.
AI logistics can reduce biotech import delays in the Global South—improving clearance, cold-chain reliability, and research timelines. See practical steps.